---
figid: PMC3763042__zh60171382890001
figlink: /pmc/articles/PMC3763042/figure/F1/
number: F1
caption: Working model of renoprotective pathways activated by relaxin. Relaxin binds
  to its receptor, RXFP-1, to activate kinase-signaling pathways (Erk, PI3K, Akt)
  and gene transcription resulting in activation of the three nitric oxide synthase
  (NOS) isoforms and production of nitric oxide (NO). Increased NO bioavailability
  results in vasodilation, increased renal blood flow, increased sodium excretion,
  and inhibition of TGF-β-Smad2 signaling. Transcription of vascular endothelial growth
  factor (VEGF) and matrix metalloproteinases is also stimulated. VEGF further stimulates
  NO production, and matrix metalloproteinases (MMPs) result in cleavage of 1) big-endothelin-1
  to stimulate the endothelin type B receptor, further stimulating NO production via
  an as yet unspecified NOS isoform and 2) collagen. Overall, these pathways result
  in improved renal function and reduced renal fibrosis. Solid black arrows indicate
  stimulatory pathways, and dashed gray lines indicate inhibitory pathways.
pmcid: PMC3763042
papertitle: The emerging role of relaxin as a novel therapeutic pathway in the treatment
  of chronic kidney disease.
reftext: Jennifer M. Sasser. Am J Physiol Regul Integr Comp Physiol. 2013 Sep 15;305(6):R559-R565.
pmc_ranked_result_index: '142623'
pathway_score: 0.949583
filename: zh60171382890001.jpg
figtitle: Working model of renoprotective pathways activated by relaxin
year: '2013'
organisms: Homo sapiens
ndex: 2a4eff53-def7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3763042__zh60171382890001.html
  '@type': Dataset
  description: Working model of renoprotective pathways activated by relaxin. Relaxin
    binds to its receptor, RXFP-1, to activate kinase-signaling pathways (Erk, PI3K,
    Akt) and gene transcription resulting in activation of the three nitric oxide
    synthase (NOS) isoforms and production of nitric oxide (NO). Increased NO bioavailability
    results in vasodilation, increased renal blood flow, increased sodium excretion,
    and inhibition of TGF-β-Smad2 signaling. Transcription of vascular endothelial
    growth factor (VEGF) and matrix metalloproteinases is also stimulated. VEGF further
    stimulates NO production, and matrix metalloproteinases (MMPs) result in cleavage
    of 1) big-endothelin-1 to stimulate the endothelin type B receptor, further stimulating
    NO production via an as yet unspecified NOS isoform and 2) collagen. Overall,
    these pathways result in improved renal function and reduced renal fibrosis. Solid
    black arrows indicate stimulatory pathways, and dashed gray lines indicate inhibitory
    pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB3
  - MAPK1
  - TGFB1
  - TGFB2
  - VEGFD
  - PGF
  - VEGFA
  - MAPK3
  - RXFP1
  - AKT1
  - AKT2
  - AKT3
  - NOS3
  - SMAD2
  - NOS1
  - VEGFB
  - VEGFC
  - NOS2
  - Nitric Oxide
genes:
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Erk+
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Erk+
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RXFP-1
  symbol: RXFP1
  source: hgnc_symbol
  hgnc_symbol: RXFP1
  entrez: '59350'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NOS3
  symbol: NOS3
  source: hgnc_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: Smad2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: NOS1
  symbol: NOS1
  source: hgnc_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: NOS2
  symbol: NOS2
  source: hgnc_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
chemicals:
- word: Nitric Oxide
  source: MESH
  identifier: D009569
diseases: []
figid_alias: PMC3763042__F1
redirect_from: /figures/PMC3763042__F1
figtype: Figure
---
